2D Ultrasound Validation to Assess the Accuracy of Hip Displacement Measurement: A Phantom Study

Author(s):  
Thanh-Tu Pham ◽  
Thanh-Giang La ◽  
Lawrence H. Le ◽  
John Andersen ◽  
Edmond Lou
2011 ◽  
Vol 196 (6) ◽  
pp. W753-W757 ◽  
Author(s):  
Katsutoshi Sugimoto ◽  
Fuminori Moriyasu ◽  
Junji Shiraishi ◽  
Masahiko Yamada ◽  
Yasuharu Imai

2015 ◽  
Vol 53 (08) ◽  
Author(s):  
R Kubale ◽  
T Fuhrmann ◽  
A Arslanow ◽  
F Frenzel ◽  
P Minko ◽  
...  

2020 ◽  
Author(s):  
PF Costa ◽  
F Süßelbeck ◽  
A Bramer ◽  
M Conti ◽  
M Weber ◽  
...  

Author(s):  
SM Dudea ◽  
C Botar-Jid ◽  
D Dumitriu ◽  
A Ciurea ◽  
A Chiorean ◽  
...  

2020 ◽  
Vol 14 (1) ◽  
pp. 012004
Author(s):  
Yosuke Tanaka ◽  
Kyosuke Yamaguchi ◽  
Kenta Yamamoto ◽  
Yoshiki Yamada

2020 ◽  
pp. 19-29
Author(s):  
Patricia Diaz Ortega ◽  
Manuel García Manero

Introduction: Symptomatic uterine fibroids can cause symptoms that can be disabling. There are many treatments, including ulipristal acetate, whose role in reducing symptoms and decreasing the size of the fibroid is well known. With this preliminary study, we also try to evaluate the correlation between myoma vascularization measured by ultrasound (Power Doppler 2D) and serum VEGF levels, before and after treatment with ulipristal acetate; in patients diagnosed with symptomatic uterine fibroids. Materials and Methods: A preliminary, prospective observational pilot study was designed. Twenty-four premenopausal women, diagnosed with symptomatic uterine fibroids, were included and all of them completed the study. Four cycles of ulipristal acetate were administered according to the dose and indications specified in the data sheet. In order to assess the influence of this treatment on the angiogenesis process of the fibroids, measurements of VEGF serum levels were made and their vascularization was assessed by means of 2D power doppler ultrasound; at the beginning and the end of treatment. In addition, several determinations of the same parameters were made throughout the successive visits. Endpoints were defined as the decrease in VEGF levels from previous levels, the decrease in myoma vascularization on ultrasound, and the reduction in myoma size. Result: 24 patients who met the inclusion criteria were enrolled (n=24). The average size of myomas was reduced from 45,08 ? 24,02mm to 29?16,96mm after treatment. The average VEGF serum level significantly decreased after the first treatment cycle (from 147,17 ? 153,51 pg/ml to 102,04 ? 186,08pg/ml). Vascularization of myomas after treatment with ulipristal acetate was analyzed, and a significantly decrease was achieved in 83,3% of cases. Conclusion: There is a correlation between myoma vascularization and treatment with Ulipristal acetate. SPRMs may provide effective treatment for women with symptomatic fibroids by two ways: supports selective progesterone receptor modulators and reduced angiogenesis. Keywords: Angiogenesis; Ulipristal Acetate; Uterine fibroids; VEGF


2019 ◽  
Vol 100 (5) ◽  
pp. 269-277 ◽  
Author(s):  
J. Greffier ◽  
A. Larbi ◽  
J. Frandon ◽  
P.A. Daviau ◽  
J.P. Beregi ◽  
...  

2012 ◽  
Vol 170-173 ◽  
pp. 2924-2928
Author(s):  
Sheng Biao Chen ◽  
Yun Zhi Tan

In order to measure the water drainage volume in soil mechanical tests accurately, it develop a new method which is based on principles of optics. And from both physical and mathematic aspects, it deduces the mathematic relationship between micro change in displacement and the increment projected on screen. The result shows that total reflection condition is better than refraction condition. What’s more, the screen could show the water volume micro variation clearly, so it can improve the accuracy of measurement.


Sign in / Sign up

Export Citation Format

Share Document